Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06042244 · ClinicalTrials.gov registry record · NA

Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis

A NA study of Multiple Sclerosis and Frailty, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT06042244 is a NA study of Multiple Sclerosis and Frailty that has completed, run by University of Kansas Medical Center. The registered enrollment target is 16 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06042244, a NA study of Multiple Sclerosis and Frailty, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Study Significance: This proposed investigation is designed to examine the feasibility of an exercise-based intervention to reduce frailty in people living with MS. The proposed research will be the first to establish the feasibility of targeting frailty in pwMS and will begin to examine the dynamic nature of frailty in MS. These advances will pave the way for planned prospective studies toward effective targets for diagnostics, and rehabilitation of frailty in MS.

Interventions

  • OTHER Waitlist
  • OTHER Multimodal Exercise Group

Study Locations (1)

Kansas

  • Landon Center On Aging - Kansas City

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2023-11-20
Est. Completion 2025-02-23
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT06042244

The ClinicalTrials.gov registry entry for NCT06042244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.

NCT06042244 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06042244 about?

NCT06042244 is a clinical study titled "Multimodal Exercise Training to Reduce Frailty in People With Multiple Sclerosis". Study Significance: This proposed investigation is designed to examine the feasibility of an exercise-based intervention to reduce frailty in people living with MS. The proposed research will be the first to establish the feasibility of targeting frailty in pwMS and will begin to examine the dynamic...

What is the current status of trial NCT06042244?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-11-20. Estimated completion is 2025-02-23.

What conditions does trial NCT06042244 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Frailty.

What interventions are being tested in trial NCT06042244?

The interventions under investigation include: Waitlist (OTHER), Multimodal Exercise Group (OTHER).

Who is sponsoring clinical trial NCT06042244?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06042244 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.